|

Experimental: chemotheyapy Clinical Trials

1 actively recruiting trial

Also known as: Vinorelbine 25mg/m2，day 1 and day 8 + Capecitabine 2000mg/m2，from day1 to DAY 14

Pipeline

Phase 2: 1

Top Sponsors

  • Henan Cancer Hospital1

Indications

  • HR Low/HER2 Negative1
  • Treatment1
  • Advanced Breast Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.